DNDi has estimated that over the next ten years a minimum of €250 million will be needed to put on the market six or seven medicines that are effective against Trypanosomiasis, Chagas Disease, and Leishmaniasis, and to have a balanced portfolio for other key medicines at various stages of development.
DNDi has estimated that over the next ten years a minimum of €250 million will be needed to put on the market six or seven medicines that are effective against Trypanosomiasis, Chagas Disease, and Leishmaniasis, and to have a balanced portfolio for other key medicines at various stages of development.